Genetic Spectrum of UGT1A1 in Korean Patients with Unconjugated Hyperbilirubinemia

被引:6
作者
Kim, Jin Ju [1 ]
Oh, Joowon [2 ]
Kim, Yoonjung [2 ]
Lee, Kyung-A [2 ]
机构
[1] Yonsei Univ, Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea
关键词
CRIGLER-NAJJAR-SYNDROME; POLYMORPHISMS;
D O I
10.3343/alm.2020.40.3.281
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:281 / 283
页数:3
相关论文
共 50 条
  • [41] Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1
    Chaouch, Leila
    Kalai, Miniar
    Darragi, Imen
    Boudrigua, Imen
    Chaouachi, Dorra
    Ben Ammar, Slim
    Mellouli, F.
    Bjaoui, M.
    Abbes, Salem
    HEMATOLOGY, 2016, 21 (02) : 121 - 125
  • [42] Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study
    Seneviratne, Herana Kamal
    Hamlin, Allyson N.
    Li, Sue
    Grinsztejn, Beatriz
    Dawood, Halima
    Liu, Albert Y.
    Kuo, Irene
    Hosseinipour, Mina C.
    Panchia, Ravindre
    Cottle, Leslie
    Chau, Gordon
    Adeyeye, Adeola
    Rinehart, Alex R.
    McCauley, Marybeth
    Eron, Joseph S.
    Cohen, Myron S.
    Landovitz, Raphael J.
    Hendrix, Craig W.
    Bumpus, Namandje N.
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2021, 4 (01) : 226 - 239
  • [43] The Association Between Heterozygosity for UGT1A1*6, UGT1A1*28, and Variation in the Serum Total-Bilirubin Level in Healthy Young Japanese Adults
    Moriya, Hiroyuki
    Saito, Katsuhiko
    Helsby, Nuala
    Sugino, Shigekazu
    Yamakage, Michiaki
    Takasaki, Masahiko
    Kato, Hidenori
    Kurosawa, Nahoko
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2013, 17 (06) : 464 - 469
  • [44] PharmGKB summary: very important pharmacogene information for UGT1A1
    Barbarino, Julia M.
    Haidar, Cyrine E.
    Klein, Teri E.
    Altman, Russ B.
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (03) : 177 - 183
  • [45] Glucuronidation of OTS167 in Humans Is Catalyzed by UDP-Glucuronosyltransferases UGT1A1, UGT1A3, UGT1A8, and UGT1A10
    Ramirez, Jacqueline
    Mirkov, Snezana
    House, Larry K.
    Ratain, Mark J.
    DRUG METABOLISM AND DISPOSITION, 2015, 43 (07) : 928 - 935
  • [46] A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation
    Cai, Hongliang
    Nguyen, Nghia
    Peterkin, Vincent
    Yang, Young-Sun
    Hotz, Kathy
    La Placa, Deirdre Beaton
    Chen, Shujuan
    Tukey, Robert H.
    Stevens, Jeffrey C.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 879 - 886
  • [47] Study on the Optimal Dose of Irinotecan for Patients with Heterozygous Uridine Diphosphate-Glucuronosyltransferase 1A1 (UGT1A1)
    Konaka, Ken
    Sakurada, Takumi
    Saito, Tatsuhiko
    Mori, Sachiko
    Imanishi, Masaki
    Kakiuchi, Soji
    Fushitani, Shuji
    Ishizawa, Keisuke
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (11) : 1839 - 1845
  • [48] Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics
    Elliot, Emilie R.
    Neary, Megan
    Else, Laura
    Khoo, Saye
    Moyle, Graeme
    Carr, Daniel F.
    Wang, Xinzhu
    Mcclure, Myra
    Boffito, Marta
    Owen, Andrew
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (05) : 1259 - 1266
  • [49] Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1
    de With, Mirjam
    van Doorn, Leni
    Kloet, Esmay
    van Veggel, Anne
    Matic, Maja
    de Neijs, Micha J.
    de Hoop, Esther
    van Meerten, Esther
    van Schaik, Ron H. N.
    Mathijssen, Ron H. J.
    Bins, Sander
    CLINICAL PHARMACOKINETICS, 2023, 62 (11) : 1589 - 1597
  • [50] The relationship between UGT1A1 gene & various diseases and prevention strategies
    Liu, Dan
    Yu, Qi
    Ning, Qing
    Liu, Zhongqiu
    Song, Jie
    DRUG METABOLISM REVIEWS, 2022, 54 (01) : 1 - 21